Advisor Group Holdings, Inc. Bridge Bio Pharma, Inc. Transaction History
Advisor Group Holdings, Inc.
- $42.2 Billion
- Q3 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 18,744 shares of BBIO stock, worth $519,396. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,744
Previous 19,788
5.28%
Holding current value
$519,396
Previous $501,000
4.79%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding BBIO
# of Institutions
291Shares Held
171MCall Options Held
10.4MPut Options Held
2.37M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$700 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$696 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$393 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$345 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$168 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.11B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...